XML 18 R4.htm IDEA: XBRL DOCUMENT v3.23.2
Unaudited Consolidated Balance Sheets - USD ($)
$ in Millions
Jun. 30, 2023
Dec. 31, 2022
Current Assets    
Cash and cash equivalents $ 1,296 $ 1,508
Trade receivables - third party and affiliates 1,338 1,379
Non-trade receivables, net 625 675
Inventories 2,514 2,808
Disposal Group, Including Discontinued Operation, Assets, Current 211 0
Other assets 268 241
Total current assets 6,252 6,611
Investments in affiliates 1,028 1,062
Property, plant and equipment (net of accumulated depreciation - 2023: $3,830; 2022: $3,687) 5,541 5,584
Operating Lease, Right-of-Use Asset 403 413
Deferred income taxes 832 808
Other assets 523 547
Goodwill 7,063 [1] 7,142
Intangible assets, net 4,007 4,105
Total assets 25,649 26,272
Current Liabilities    
Short-term borrowings and current installments of long-term debt - third party and affiliates 1,507 1,306
Trade payables - third party and affiliates 1,243 1,518
Disposal Group, Including Discontinued Operation, Liabilities, Current 19 0
Other liabilities 1,146 1,201
Income taxes payable 7 43
Total current liabilities 3,922 4,068
Long-term debt, net of unamortized deferred financing costs 12,889 13,373
Deferred income taxes 1,220 1,242
Uncertain tax positions 285 322
Benefit obligations 406 411
Operating lease liabilities 347 364
Other liabilities 492 387
Commitments and Contingencies
Shareholders' Equity    
Preferred stock, $0.01 par value, 100,000,000 shares authorized (2023 and 2022: 0 issued and outstanding) 0 0
Common stock, $0.0001 par value, 400,000,000 shares authorized (2023: 170,458,836 issued and 108,847,435 outstanding; 2022: 170,135,425 issued and 108,473,932 outstanding) 0 0
Treasury stock, at cost (2023: 61,611,401 shares; 2022: 61,661,493 shares) (5,490) (5,491)
Additional paid-in capital 383 372
Retained earnings 11,433 11,274
Accumulated other comprehensive income (loss), net (702) (518)
Total Celanese Corporation shareholders' equity 5,624 5,637
Noncontrolling interests 464 468
Total equity 6,088 6,105
Total liabilities and equity $ 25,649 $ 26,272
[1] There were no accumulated impairment losses as of June 30, 2023.